MedPath
HSA Approval

TETRADOX CAPSULE 100 mg

SIN06906P

TETRADOX CAPSULE 100 mg

TETRADOX CAPSULE 100 mg

March 20, 1992

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01AA02

doxycycline

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN BHD

Active Ingredients

DOXYCYCLINE HYCLATE 115.4mg EQV DOXYCYCLINE

100 mg

Doxycycline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TETRADOX CAPSULE 100 mg - HSA Approval | MedPath